Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE (Details)

v3.22.2
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 5 Months Ended 6 Months Ended
Jun. 30, 2021
May 17, 2021
Jun. 30, 2022
Mar. 31, 2022
Mar. 31, 2021
May 17, 2021
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Net (loss) income $ (209,586) $ 242,214 $ 256,580 $ (491,975) $ 8,780 $ 250,994 $ (235,395)
Dividends on preferred stock (1,031) 0 (1,380)     0 (2,828)
Participating securities - preferred stock 0 0 (39,590)        
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS (210,617) 242,214 215,610     250,994 (238,223)
Re-allocation of participating securities 0 0 310        
Net (loss) income attributable to common stockholders, diluted $ (210,617) $ 242,214 $ 215,920     $ 250,994 $ (238,223)
Basic shares (in shares) 20,321,000 160,887,000 20,684,000     160,834,000 20,961,000
Dilutive shares (in shares) 20,321,000 160,887,000 20,877,000     160,834,000 20,961,000
Basic EPS (in usd per share) $ (10.36) $ 1.51 $ 10.42     $ 1.56 $ (11.36)
Dilutive EPS (in usd per share) $ (10.36) $ 1.51 $ 10.34     $ 1.56 $ (11.36)
Common Stock              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Anti-dilutive shares (in shares) 0 0 200,000     0 0
Series A Convertible Preferred Stock              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Anti-dilutive shares (in shares)     3,800,000       3,800,000
Restricted Stock              
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]              
Anti-dilutive shares (in shares)     0       200,000